Vegf Therapy: How It Works, Results and What to Expect

VEGF therapy usually refers to anti-VEGF medicines injected into the eye to block a protein that drives abnormal blood vessel growth and leakage. It is commonly used to stabilize vision and, for some people, improve it in retinal conditions such as wet age-related macular degeneration and diabetic macular edema.

Overview: what is VEGF therapy?

VEGF therapy in eye care generally means anti-VEGF therapy: medicines that block vascular endothelial growth factor (VEGF). VEGF is a natural signaling protein involved in blood vessel growth. In some retinal diseases, however, too much VEGF contributes to fragile abnormal blood vessels, bleeding, swelling and fluid leakage that can blur or distort central vision.

An ophthalmologist delivers anti-VEGF medicine by injection into the vitreous, the gel inside the eye. By reducing VEGF activity, treatment can dry retinal fluid, limit further damage and help protect sight. It is widely used for wet age-related macular degeneration, diabetic macular edema, retinal vein occlusion-related macular edema and some other retinal conditions.

The term can be confusing because VEGF has helpful roles elsewhere in the body. In this context, a VEGF inhibitor is used locally in the eye to address disease-related blood vessel leakage. The treatment plan is individualized according to the diagnosis, retinal scan findings and each person’s VEGF response over time.

How does VEGF inhibitor therapy work?

The retina is the light-sensitive tissue lining the back of the eye. Its central area, the macula, is responsible for detailed tasks such as reading, recognizing faces and driving. When fluid collects in or beneath the macula, vision may become blurred, wavy or less sharp.

Anti-VEGF medicines attach to VEGF or interfere with its action. This helps reduce permeability, meaning that blood vessels are less likely to leak fluid, and it can suppress the growth of harmful new vessels. On optical coherence tomography (OCT), a noninvasive retinal scan, doctors may see reduced swelling or fluid after treatment.

VEGF therapeutic treatment does not remove the underlying tendency for the condition to recur. The medicine gradually clears from the eye, so repeat injections are frequently needed. Some people begin with closely spaced treatments and later move to longer intervals if the retina remains stable; others need a different schedule or medicine. Regular review helps the retinal specialist make these decisions safely.

Who may be a candidate for anti-VEGF eye injections?

A retinal specialist may recommend VEGF therapy when imaging and examination show that retinal fluid or abnormal blood vessels are affecting, or threatening, vision. Common reasons include wet age-related macular degeneration, diabetic macular edema, macular edema after retinal vein occlusion, and myopic choroidal neovascularization. These conditions may have overlapping symptoms but need an accurate diagnosis because their management differs.

Assessment commonly includes a vision test, dilated eye examination and OCT imaging. Fluorescein angiography or other testing may occasionally be used to map abnormal blood vessels or leakage. The clinician also reviews previous eye treatments, medications, allergies, pregnancy status when relevant, and general health concerns.

Anti-VEGF treatment may be postponed if there is an active eye or eyelid infection. People should tell their clinician about recent surgery, a history of stroke or heart problems, and any new symptoms. These factors do not automatically rule out therapy, but they help the care team weigh benefits and risks appropriately. Managing diabetes, blood pressure and other vascular risk factors is also important for people with retinal vascular disease.

What happens during a VEGF eye injection?

Intravitreal anti-VEGF injection is usually an outpatient procedure. The visit may include a vision check and retinal imaging before the injection. The eye is numbed with anesthetic drops or gel, and the eyelids and surrounding skin are cleaned with antiseptic. A small device may gently hold the eyelids open.

The specialist then injects a small amount of medication through the white part of the eye. The injection itself takes only seconds. Most people describe pressure, brief discomfort or awareness of the procedure rather than significant pain. The eye is checked afterward, and the care team provides written aftercare instructions.

Temporary blurring, a scratchy feeling, watering and small floating spots are common soon afterward. Arranging transport home is often practical because vision can be blurred from drops or the procedure. Depending on the condition, treatment may be delivered monthly at first, at fixed intervals, or using a treat-and-extend approach guided by examination and OCT results.

• Before treatment, report eye redness, discharge, fever or a suspected infection.
• During follow-up, bring any changes in vision, distortion or new blind spots to the specialist’s attention.
• Keep every planned review visit, even if vision seems unchanged, as fluid can return before symptoms are obvious.

How long does it take for a VEGF eye injection to work?

Some people notice less distortion or clearer vision within days to a few weeks, particularly when treatment quickly reduces retinal fluid. For others, vision changes are more gradual and may take several injections. OCT imaging can sometimes show an early reduction in fluid before a person notices a meaningful change in sight.

How quickly treatment works depends on the underlying condition, how much fluid or bleeding is present, how long the retina has been affected and the degree of existing retinal damage. A favorable VEGF response may mean less fluid on scans, stable or improved vision, or both. Visual improvement and scan improvement do not always happen at the same pace.

The specialist usually evaluates response at follow-up appointments rather than judging success from one injection alone. If fluid persists or returns, the clinician may adjust the interval, consider another anti-VEGF medicine, or look for other factors contributing to reduced vision. Early treatment and consistent monitoring can be important for preserving retinal function.

What is the success rate of anti-VEGF injections?

There is no single success rate for anti-VEGF injections because outcomes vary by diagnosis, disease stage, medication, treatment schedule and how consistently follow-up care is received. In clinical practice, the main goals are often to prevent further vision loss, reduce fluid and maintain the ability to perform daily visual tasks. Many people achieve stabilization, and some gain vision.

Results are generally better when treatment begins before substantial irreversible retinal scarring or loss of light-sensing cells has occurred. A person with long-standing disease may still benefit from controlling active leakage, even if major visual improvement is unlikely. The specialist can explain the likely goals based on the retinal examination and imaging rather than promising a particular outcome.

Anti-VEGF therapy is usually one component of long-term eye care. For example, people with diabetes benefit from coordinated control of blood glucose, blood pressure and cholesterol alongside retinal treatment. If another eye condition, such as cataract, glaucoma or dry eye, also affects vision, addressing it may help clarify what improvement can reasonably be expected.

Do anti-VEGF injections restore vision? Benefits and possible risks

Anti-VEGF injections can improve vision for some people, especially when blurring is due to fluid that can resolve. They are also valuable when they prevent further deterioration. However, they cannot reliably restore vision lost from permanent macular scarring, advanced retinal cell damage or other unrelated eye disease. Treatment expectations should focus on the individual’s retinal findings and functional goals.

Common VEGF therapy side effects are usually temporary and include mild eye discomfort, redness on the white of the eye, tearing, sensitivity to light, floaters and blurred vision. A small red patch at the injection site can look concerning but often settles as the surface heals. The treating team can advise on safe comfort measures and whether any usual eye drops should be continued.

Rare but serious complications include infection inside the eye, retinal detachment, significant bleeding, a sudden rise in eye pressure and severe inflammation. Systemic complications are uncommon, but medical history is considered because anti-VEGF medicines affect a pathway involved in blood vessels. Urgent assessment is needed for severe or increasing pain, rapidly worsening vision, increasing redness, pus-like discharge, marked light sensitivity, or a curtain-like shadow in the vision.

What not to do after an anti-VEGF injection and when to seek medical care

For the rest of the day, people should avoid rubbing or pressing on the treated eye. They should use only eye drops recommended by their clinician and avoid swimming, hot tubs and potentially contaminated water until the care team says it is appropriate. Heavy physical restriction is not always necessary, but the individual aftercare plan should take priority, particularly after a difficult injection or when other eye procedures have been performed.

It is sensible to avoid driving until vision is clear enough to do so safely. A gritty sensation, mild redness and small floaters may occur in the first day or two. People should not assume that a new or worsening symptom is normal; contacting the eye clinic for advice is appropriate whenever there is uncertainty.

Medical care should be sought urgently if there is severe pain, a sharp or persistent decrease in vision, worsening redness, swelling around the eye, pronounced sensitivity to light, nausea with eye pain, or new flashes, many floaters or a shadow moving across the visual field. These symptoms are uncommon but can signal complications that need prompt treatment.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat retinal conditions for international patients, with treatment planning based on ophthalmic examination and imaging findings.

Frequently asked questions

How long does it take for a VEGF eye injection to work?

Retinal fluid may begin to reduce within days to weeks, and some people notice visual improvement during that time. Others need several injections before their vision or OCT scan shows a clear response. The timing depends on the condition, the severity of swelling and whether permanent retinal damage is present.

What is the success rate of anti-VEGF injections?

A single percentage cannot describe success for every person because the diagnosis, stage of disease, medicine and treatment schedule all affect results. Anti-VEGF injections often help stabilize vision and reduce retinal fluid, while some people also gain vision. A retinal specialist can discuss the expected benefit using the individual's examination and imaging results.

What not to do after an anti-VEGF injection?

Do not rub or press on the treated eye, and use only the drops recommended by the treating team. Avoid swimming and hot tubs until the clinician advises that it is safe, and do not drive while vision remains blurry. Follow the specific instructions provided by the eye clinic, as recommendations can differ between patients.

Do anti-VEGF injections restore vision?

They can improve vision when fluid or leakage is causing reversible blurring, and they can help prevent further sight loss. They may not restore vision if the macula has permanent scarring or advanced retinal cell damage. The goal is often to preserve as much useful vision as possible over time.

Are anti-VEGF eye injections painful?

The eye is numbed before the injection, so most people feel pressure, mild discomfort or a brief sensation rather than significant pain. Mild grittiness or irritation afterward is common and generally short-lived. Severe pain is not expected and should be reported urgently to the treating clinic.

How often are anti-VEGF injections needed?

The schedule depends on the retinal condition and how the eye responds to treatment. Some people need injections every few weeks at the beginning, followed by longer intervals when scans remain stable. Others need ongoing regular treatment because fluid can recur when the medicine's effect fades.

References

• American Academy of Ophthalmology
• National Eye Institute
• National Health Service
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.